In particular, the tumour-proliferative rate measured as Ki-67, Mib-1 or thymidine labelling index is rapidly and significantly inhibited by hormonal treatment or chemotherapy (Collecchi et al, 1998; Colleoni et al, 1999; Archer et al, 2003). The gene discussed is MIB1; the disease is neoplasm.